Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 1.81
VAR's Cash-to-Debt is ranked lower than
58% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 2.54 vs. VAR: 1.81 )
Ranked among companies with meaningful Cash-to-Debt only.
VAR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.24  Med: 3.96 Max: N/A
Current: 1.81
Equity-to-Asset 0.45
VAR's Equity-to-Asset is ranked lower than
80% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.65 vs. VAR: 0.45 )
Ranked among companies with meaningful Equity-to-Asset only.
VAR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.32  Med: 0.52 Max: 0.6
Current: 0.45
0.32
0.6
Interest Coverage 44.03
VAR's Interest Coverage is ranked lower than
59% of the 220 Companies
in the Global Medical Devices industry.

( Industry Median: 73.23 vs. VAR: 44.03 )
Ranked among companies with meaningful Interest Coverage only.
VAR' s Interest Coverage Range Over the Past 10 Years
Min: 44.03  Med: 100.85 Max: 226.41
Current: 44.03
44.03
226.41
Piotroski F-Score: 8
Altman Z-Score: 5.59
Beneish M-Score: -2.78
WACC vs ROIC
6.85%
25.81%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating Margin % 14.66
VAR's Operating Margin % is ranked higher than
79% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 3.45 vs. VAR: 14.66 )
Ranked among companies with meaningful Operating Margin % only.
VAR' s Operating Margin % Range Over the Past 10 Years
Min: 14.66  Med: 20.48 Max: 22.67
Current: 14.66
14.66
22.67
Net Margin % 8.30
VAR's Net Margin % is ranked higher than
74% of the 303 Companies
in the Global Medical Devices industry.

( Industry Median: 1.77 vs. VAR: 8.30 )
Ranked among companies with meaningful Net Margin % only.
VAR' s Net Margin % Range Over the Past 10 Years
Min: 8.3  Med: 14.03 Max: 15.36
Current: 8.3
8.3
15.36
ROE % 18.16
VAR's ROE % is ranked higher than
86% of the 295 Companies
in the Global Medical Devices industry.

( Industry Median: 2.13 vs. VAR: 18.16 )
Ranked among companies with meaningful ROE % only.
VAR' s ROE % Range Over the Past 10 Years
Min: 18.16  Med: 27.57 Max: 31.67
Current: 18.16
18.16
31.67
ROA % 8.15
VAR's ROA % is ranked higher than
78% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: 0.49 vs. VAR: 8.15 )
Ranked among companies with meaningful ROA % only.
VAR' s ROA % Range Over the Past 10 Years
Min: 8.15  Med: 14.94 Max: 16.54
Current: 8.15
8.15
16.54
ROC (Joel Greenblatt) % 73.41
VAR's ROC (Joel Greenblatt) % is ranked higher than
87% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 6.15 vs. VAR: 73.41 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
VAR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 73.41  Med: 95.9 Max: 112.94
Current: 73.41
73.41
112.94
3-Year Revenue Growth Rate 7.80
VAR's 3-Year Revenue Growth Rate is ranked higher than
59% of the 239 Companies
in the Global Medical Devices industry.

( Industry Median: 5.30 vs. VAR: 7.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
VAR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -27.1  Med: 10.95 Max: 17.4
Current: 7.8
-27.1
17.4
3-Year EBITDA Growth Rate 3.00
VAR's 3-Year EBITDA Growth Rate is ranked lower than
58% of the 210 Companies
in the Global Medical Devices industry.

( Industry Median: 6.30 vs. VAR: 3.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
VAR' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -47.6  Med: 12.4 Max: 65.2
Current: 3
-47.6
65.2
3-Year EPS without NRI Growth Rate 1.70
VAR's 3-Year EPS without NRI Growth Rate is ranked lower than
51% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 2.90 vs. VAR: 1.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
VAR' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -58.5  Med: 14.85 Max: 113.8
Current: 1.7
-58.5
113.8
GuruFocus has detected 4 Warning Signs with Varian Medical Systems Inc $VAR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» VAR's 30-Y Financials

Financials (Next Earnings Date: 2017-10-26 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

VAR Guru Trades in Q3 2016

Jim Simons 11,500 sh (New)
Steven Cohen 10,500 sh (New)
Richard Pzena 2,998 sh (New)
Columbia Wanger 398,000 sh (New)
Paul Tudor Jones 8,463 sh (+14.24%)
John Rogers 24,968 sh (+6.40%)
Ray Dalio Sold Out
First Eagle Investment 4,316,310 sh (-0.22%)
Charles Brandes 156,511 sh (-7.41%)
CI Can Am Small Cap 52,355 sh (-11.64%)
» More
Q4 2016

VAR Guru Trades in Q4 2016

Joel Greenblatt 337,618 sh (New)
John Hussman 10,000 sh (New)
Paul Tudor Jones 18,666 sh (+120.56%)
Charles Brandes 163,536 sh (+4.49%)
First Eagle Investment 4,318,060 sh (+0.04%)
Jim Simons Sold Out
Steven Cohen Sold Out
Richard Pzena 2,860 sh (-4.60%)
Columbia Wanger 333,900 sh (-16.11%)
John Rogers 20,100 sh (-19.50%)
» More
Q1 2017

VAR Guru Trades in Q1 2017

Steven Cohen 355,900 sh (New)
John Hussman 10,900 sh (+9.00%)
First Eagle Investment 4,641,466 sh (+7.49%)
John Rogers 20,918 sh (+4.07%)
Charles Brandes 166,487 sh (+1.80%)
CI Can Am Small Cap 52,355 sh (unchged)
Richard Pzena Sold Out
Paul Tudor Jones Sold Out
Columbia Wanger 304,513 sh (-8.80%)
Joel Greenblatt 106,226 sh (-68.54%)
» More
Q2 2017

VAR Guru Trades in Q2 2017

George Soros 5,100 sh (New)
Caxton Associates 5,800 sh (New)
Ray Dalio 12,783 sh (New)
Joel Greenblatt 403,452 sh (+279.81%)
Steven Cohen 537,816 sh (+51.11%)
First Eagle Investment 4,679,471 sh (+0.82%)
John Hussman 10,900 sh (unchged)
Charles Brandes Sold Out
John Rogers Sold Out
Columbia Wanger 196,943 sh (-35.33%)
» More
» Details

Insider Trades

Latest Guru Trades with VAR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
First Eagle Investment 2017-06-30 Add 0.82%0.01%$88.37 - $105.03 $ 99.714%4,679,471
Joel Greenblatt 2017-06-30 Add 279.81%0.43%$88.37 - $105.03 $ 99.714%403,452
George Soros 2017-06-30 New Buy0.01%$88.37 - $105.03 $ 99.714%5,100
John Rogers 2017-06-30 Sold Out 0.02%$88.37 - $105.03 $ 99.714%0
Charles Brandes 2017-06-30 Sold Out 0.23%$88.37 - $105.03 $ 99.714%0
First Eagle Investment 2017-03-31 Add 7.49%0.07%$76.57 - $91.65 $ 99.7119%4,641,466
Charles Brandes 2017-03-31 Add 1.80%$76.57 - $91.65 $ 99.7119%166,487
Joel Greenblatt 2017-03-31 Reduce -68.54%0.14%$76.57 - $91.65 $ 99.7119%106,226
John Rogers 2017-03-31 Add 4.07%$76.57 - $91.65 $ 99.7119%20,918
Richard Pzena 2017-03-31 Sold Out $76.57 - $91.65 $ 99.7119%0
First Eagle Investment 2016-12-31 Add 0.04%$77.79 - $88.81 $ 99.7122%4,318,060
Joel Greenblatt 2016-12-31 New Buy0.2%$77.79 - $88.81 $ 99.7122%337,618
Charles Brandes 2016-12-31 Add 4.49%0.01%$77.79 - $88.81 $ 99.7122%163,536
John Rogers 2016-12-31 Reduce -19.50%0.01%$77.79 - $88.81 $ 99.7122%20,100
Richard Pzena 2016-12-31 Reduce -4.60%$77.79 - $88.81 $ 99.7122%2,860
First Eagle Investment 2016-09-30 Reduce -0.22%$72.45 - $88.18 $ 99.7121%4,316,310
Charles Brandes 2016-09-30 Reduce -7.41%0.02%$72.45 - $88.18 $ 99.7121%156,511
John Rogers 2016-09-30 Add 6.40%$72.45 - $88.18 $ 99.7121%24,968
Richard Pzena 2016-09-30 New Buy$72.45 - $88.18 $ 99.7121%2,998
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3844
Compare:NYSE:TFX, NAS:ABMD, NAS:MASI, NAS:ALGN, NAS:IART, NAS:NUVA, NYSE:PEN, NYSE:GMED, NYSE:NVRO, NAS:INGN, NAS:SPNC, NAS:MDXG, NYSE:ITGR, NAS:CNMD, NAS:BABY, NAS:KTWO, NAS:CSII, NAS:XENT, NYSE:CRY, NAS:GNMK » details
Traded in other countries:VNM.Germany,
Headquarter Location:USA
Varian Medical Systems Inc is engaged in the healthcare sector. It manufactures medical devices for conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (51%), followed by Europe, the Middle East, and Africa (29%) and Asia-Pacific (20%).

Guru Investment Theses on Varian Medical Systems Inc

Wedgewood Partners Comments on Varian Medical Systems - Jan 18, 2016

We sold Varian Medical Systems (NYSE:VAR) early in the quarter. The Company maintains its position as the dominant supplier of radiotherapy equipment and software, worldwide. We see Varian’s core business growing earnings per share at a steady, low to mid-single digit rate, as developed markets have reached maturity. In addition, the dramatic devaluation of the Japanese yen relative to the U.S. Dollar has caused some competitive pressures in its non-core Imaging and Components segment, further pressuring growth. While Imaging Components might regain competitiveness over the next few years, we do not think it will be enough to drive earnings growth to our required rate.



From Wedgewood Partners' fourth quarter 2015 client letter.



Check out David Rolfe latest stock trades

Ratios

vs
industry
vs
history
PE Ratio 32.80
VAR's PE Ratio is ranked lower than
53% of the 179 Companies
in the Global Medical Devices industry.

( Industry Median: 30.71 vs. VAR: 32.80 )
Ranked among companies with meaningful PE Ratio only.
VAR' s PE Ratio Range Over the Past 10 Years
Min: 10.77  Med: 18.35 Max: 34.93
Current: 32.8
10.77
34.93
Forward PE Ratio 22.22
VAR's Forward PE Ratio is ranked higher than
63% of the 49 Companies
in the Global Medical Devices industry.

( Industry Median: 25.64 vs. VAR: 22.22 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 26.66
VAR's PE Ratio without NRI is ranked lower than
52% of the 178 Companies
in the Global Medical Devices industry.

( Industry Median: 31.10 vs. VAR: 26.66 )
Ranked among companies with meaningful PE Ratio without NRI only.
VAR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 9.86  Med: 18.33 Max: 28.4
Current: 26.66
9.86
28.4
Price-to-Owner-Earnings 40.24
VAR's Price-to-Owner-Earnings is ranked lower than
73% of the 109 Companies
in the Global Medical Devices industry.

( Industry Median: 36.31 vs. VAR: 40.24 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
VAR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 13.61  Med: 21.22 Max: 57.44
Current: 40.24
13.61
57.44
PB Ratio 6.59
VAR's PB Ratio is ranked lower than
82% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 2.92 vs. VAR: 6.59 )
Ranked among companies with meaningful PB Ratio only.
VAR' s PB Ratio Range Over the Past 10 Years
Min: 2.71  Med: 4.49 Max: 7.92
Current: 6.59
2.71
7.92
PS Ratio 2.73
VAR's PS Ratio is ranked higher than
52% of the 290 Companies
in the Global Medical Devices industry.

( Industry Median: 3.32 vs. VAR: 2.73 )
Ranked among companies with meaningful PS Ratio only.
VAR' s PS Ratio Range Over the Past 10 Years
Min: 1.43  Med: 2.55 Max: 4.13
Current: 2.73
1.43
4.13
Price-to-Free-Cash-Flow 25.79
VAR's Price-to-Free-Cash-Flow is ranked lower than
53% of the 110 Companies
in the Global Medical Devices industry.

( Industry Median: 32.13 vs. VAR: 25.79 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
VAR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.87  Med: 19.76 Max: 41.13
Current: 25.79
12.87
41.13
Price-to-Operating-Cash-Flow 22.15
VAR's Price-to-Operating-Cash-Flow is ranked lower than
62% of the 135 Companies
in the Global Medical Devices industry.

( Industry Median: 19.50 vs. VAR: 22.15 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
VAR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 10.2  Med: 15.91 Max: 32.68
Current: 22.15
10.2
32.68
EV-to-EBIT 17.14
VAR's EV-to-EBIT is ranked higher than
56% of the 177 Companies
in the Global Medical Devices industry.

( Industry Median: 24.67 vs. VAR: 17.14 )
Ranked among companies with meaningful EV-to-EBIT only.
VAR' s EV-to-EBIT Range Over the Past 10 Years
Min: 6  Med: 11.9 Max: 19.2
Current: 17.14
6
19.2
EV-to-EBITDA 14.80
VAR's EV-to-EBITDA is ranked higher than
52% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: 17.99 vs. VAR: 14.80 )
Ranked among companies with meaningful EV-to-EBITDA only.
VAR' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.5  Med: 10.8 Max: 17.6
Current: 14.8
5.5
17.6
PEG Ratio 7.03
VAR's PEG Ratio is ranked lower than
83% of the 83 Companies
in the Global Medical Devices industry.

( Industry Median: 2.26 vs. VAR: 7.03 )
Ranked among companies with meaningful PEG Ratio only.
VAR' s PEG Ratio Range Over the Past 10 Years
Min: 0.67  Med: 1.21 Max: 20.58
Current: 7.03
0.67
20.58
Shiller PE Ratio 27.98
VAR's Shiller PE Ratio is ranked higher than
79% of the 53 Companies
in the Global Medical Devices industry.

( Industry Median: 49.44 vs. VAR: 27.98 )
Ranked among companies with meaningful Shiller PE Ratio only.
VAR' s Shiller PE Ratio Range Over the Past 10 Years
Min: 19.19  Med: 25.41 Max: 39.87
Current: 27.98
19.19
39.87
Current Ratio 1.62
VAR's Current Ratio is ranked lower than
77% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 2.64 vs. VAR: 1.62 )
Ranked among companies with meaningful Current Ratio only.
VAR' s Current Ratio Range Over the Past 10 Years
Min: 1.38  Med: 1.85 Max: 2.33
Current: 1.62
1.38
2.33
Quick Ratio 1.26
VAR's Quick Ratio is ranked lower than
72% of the 319 Companies
in the Global Medical Devices industry.

( Industry Median: 1.92 vs. VAR: 1.26 )
Ranked among companies with meaningful Quick Ratio only.
VAR' s Quick Ratio Range Over the Past 10 Years
Min: 1.04  Med: 1.47 Max: 1.87
Current: 1.26
1.04
1.87
Days Inventory 108.24
VAR's Days Inventory is ranked higher than
51% of the 285 Companies
in the Global Medical Devices industry.

( Industry Median: 128.08 vs. VAR: 108.24 )
Ranked among companies with meaningful Days Inventory only.
VAR' s Days Inventory Range Over the Past 10 Years
Min: 75.59  Med: 97.51 Max: 123.11
Current: 108.24
75.59
123.11
Days Sales Outstanding 79.67
VAR's Days Sales Outstanding is ranked lower than
68% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 68.17 vs. VAR: 79.67 )
Ranked among companies with meaningful Days Sales Outstanding only.
VAR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 79.67  Med: 90.38 Max: 105.45
Current: 79.67
79.67
105.45
Days Payable 28.63
VAR's Days Payable is ranked lower than
78% of the 258 Companies
in the Global Medical Devices industry.

( Industry Median: 54.45 vs. VAR: 28.63 )
Ranked among companies with meaningful Days Payable only.
VAR' s Days Payable Range Over the Past 10 Years
Min: 28.63  Med: 38.92 Max: 41.88
Current: 28.63
28.63
41.88

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 4.20
VAR's 3-Year Average Share Buyback Ratio is ranked higher than
98% of the 226 Companies
in the Global Medical Devices industry.

( Industry Median: -4.10 vs. VAR: 4.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
VAR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -3.5  Med: 1.55 Max: 4.7
Current: 4.2
-3.5
4.7

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 23.52
VAR's Price-to-Net-Current-Asset-Value is ranked lower than
89% of the 204 Companies
in the Global Medical Devices industry.

( Industry Median: 6.83 vs. VAR: 23.52 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
VAR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.53  Med: 11.34 Max: 39.93
Current: 23.52
6.53
39.93
Price-to-Tangible-Book 8.37
VAR's Price-to-Tangible-Book is ranked lower than
80% of the 256 Companies
in the Global Medical Devices industry.

( Industry Median: 3.98 vs. VAR: 8.37 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
VAR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.2  Med: 5.8 Max: 10.54
Current: 8.37
3.2
10.54
Price-to-Intrinsic-Value-Projected-FCF 2.02
VAR's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
58% of the 141 Companies
in the Global Medical Devices industry.

( Industry Median: 2.41 vs. VAR: 2.02 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
VAR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.85  Med: 1.36 Max: 3.92
Current: 2.02
0.85
3.92
Price-to-Intrinsic-Value-DCF (Earnings Based) 1.87
VAR's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
52% of the 27 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. VAR: 1.87 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.07
VAR's Price-to-Median-PS-Value is ranked lower than
64% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 1.01 vs. VAR: 1.07 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
VAR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.62  Med: 1.08 Max: 1.84
Current: 1.07
0.62
1.84
Price-to-Graham-Number 3.15
VAR's Price-to-Graham-Number is ranked lower than
66% of the 140 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. VAR: 3.15 )
Ranked among companies with meaningful Price-to-Graham-Number only.
VAR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.66  Med: 2.35 Max: 4.04
Current: 3.15
0.66
4.04
Earnings Yield (Greenblatt) % 5.83
VAR's Earnings Yield (Greenblatt) % is ranked higher than
76% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 1.25 vs. VAR: 5.83 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
VAR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.2  Med: 8.4 Max: 16.8
Current: 5.83
5.2
16.8
Forward Rate of Return (Yacktman) % 4.94
VAR's Forward Rate of Return (Yacktman) % is ranked lower than
63% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.78 vs. VAR: 4.94 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
VAR' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 4.7  Med: 19.2 Max: 28.5
Current: 4.94
4.7
28.5

More Statistics

Revenue (TTM) (Mil) $3,424.60
EPS (TTM) $ 3.04
Beta0.82
Short Percentage of Float7.37%
52-Week Range $75.94 - 107.08
Shares Outstanding (Mil)91.80

Analyst Estimate

Sep17 Sep18 Sep19
Revenue (Mil $) 2,770 2,803 2,859
EPS ($) 4.05 4.49 4.60
EPS without NRI ($) 4.05 4.49 4.60
EPS Growth Rate
(Future 3Y To 5Y Estimate)
7.21%
Dividends per Share ($)
» More Articles for VAR

Headlines

Articles On GuruFocus.com
Varian Medical Systems to Hold Investor Meeting at ASTRO in San Diego Aug 14 2017 
Varian Announces New VP of Investor Relations Aug 10 2017 
Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation T Aug 09 2017 
Varian Selected to Provide Full Range of Software for New Proton Therapy Centers in UK and Denmark Aug 01 2017 
PetCure Oncology Selects Varian Halcyon Treatment System to Expand Access to Cancer Care for Pets Jul 27 2017 
Varian Installs Cyclotron at Georgia Proton Treatment Center Jul 26 2017 
UZ Leuven Orders Varian Halcyon Cancer Treatment System Jul 26 2017 
Varian to Showcase Latest Radiotherapy and Radiosurgery Technologies and Software at AAPM 2017 Jul 25 2017 
Varian Eclipse Users Generate Highest Scoring Plans in International Treatment Plan Competition Jul 18 2017 
Leading Cancer Center Commences Advanced Treatments Using Varian Edge™ Radiosurgery System Jul 11 2017 

More From Other Websites
Varian Medical Systems’ Recent Stock Performance Aug 16 2017
What Drove Varian to Revise Its Revenue Guidance Aug 16 2017
Varian (VAR) Rides on Oncology and Proton Therapy Businesses Aug 16 2017
How Varian Is Harnessing Proton Therapy Market Opportunities Aug 16 2017
Varian’s Halcyon Treatment System Sees Emerging Market Demand Aug 15 2017
Varian’s Oncology Business Grows in Emerging Markets Aug 15 2017
Why Varian Medical Systems’ Profitability Is Improving Aug 15 2017
A Look at Varian Medical Systems’ Long-Term Goals Aug 14 2017
Varian Medical Systems: Better Aligned, More Focused Aug 14 2017
Varian Medical Systems to Hold Investor Meeting at ASTRO in San Diego Aug 14 2017
Analysts’ Recommendations for Varian Medical Systems Aug 14 2017
Edited Transcript of VAR earnings conference call or presentation 26-Jul-17 9:00pm GMT Aug 11 2017
See what the IHS Markit Score report has to say about Varian Medical Systems Inc. Aug 11 2017
Corporate News Blog - Bionix(R) Radiation Therapy Signs on Varian Medical Systems as Distributor for... Aug 11 2017
Varian Medical Systems, Inc. :VAR-US: Earnings Analysis: Q3, 2017 By the Numbers : August 10, 2017 Aug 10 2017
Varian Medical (VAR) Signs Distribution Deal with Bionix Aug 10 2017
Varian Announces New VP of Investor Relations Aug 10 2017
Varian Medical Systems Signs Brachytherapy Applicator Distribution Agreement with Bionix Radiation... Aug 09 2017
First Patient Treated with Varian HyperArc High Definition Radiotherapy Aug 08 2017
Earnings Review and Free Research Report: Varian Medical Systems Reported Better than Expected... Aug 07 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)